New scan may clarify prostate cancer return when standard test fails
NCT ID NCT07569926
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This study tests whether a special PET scan using fluciclovine can help doctors decide on treatment for prostate cancer that has come back after initial therapy. It includes 142 men whose previous PSMA PET scan was negative or unclear. The main goal is to see if the fluciclovine scan changes how the cancer is managed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emory University
Atlanta, Georgia, 30322, United States
Contact
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Contact
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
Contact
-
Washington University
St Louis, Missouri, 63110, United States
Contact
Conditions
Explore the condition pages connected to this study.